The Drug Controller General of India (DCGI) has approved the new drug application (NDA) for Saroglitazar Mg for the treatment of non-alcoholic fatty liver disease (NAFLD) in India, Zydus Cadila said in a regulatory filing.from Moneycontrol Business News https://ift.tt/2MjQTfu
No comments:
Post a Comment